Fetomaternal Medicine

Friday, July 20, 2012


08:30-10:00
PRENATAL ULTRASOUND SCREENING
Capsule  
Ultrasound screening for anomaly is evolving rapidly and is being done at ever earlier stage

Chairpersons H. Divakar, India
S. Lipitz, Israel
08:30-08:50 Is it time to abandon NT for very early anomaly scan?
R. Achiron, Israel
08:50-09:15 Genetic ultrasound at 14 weeks.
C. Anandakumar
, Singapore
09:15-09:35 What is the next step after abnormal NT/Early abnormal scan CVS /Amnio?
G. Yeo, Singapore
09:35-10:00 Is there a role for Ultrasound at Delivery Room?
Y. Gilboa, Israel
Objectives Should we combine early scan and NT?
What should be the next step when anomaly is suspected?
What is intra partum ultrasound screening?

10:00-10:20 Coffee break

10:20-11:50
UNDERSTANDING THE SCIENCE & MANAGEMENT OF POST-OPERATIVE SCAR
Supported by an unrestricted grant from Invida
Chairperson C. Chong, Singapore
10:20-10:25 Opening Remarks & Introduction of Speaker by the Chairperson
10:25-11:10 Multimodality Scar Therapy - The path to meticulous results
G. Chernoff, USA
11:10-11:30 Scars and the skin (Managing fresh scars)
A. Cumagun, Philippines
11:30-11:45 Open Forum
G. Chernoff, USA
A. Cumagun, Philippines
11:45-11:50 Closing remarks by the Chairperson

11:50-12:10 Poster viewing

12:10-13:40
MULTIPLE PREGNANCIES
Capsule
  
The sharp increase in multiple pregnancies continues to be a major risk factor in pregnancy and delivery
Chairpersons M. Carrapato, Portugal
T.Y. Leung, Hong Kong
12:10-12:30 Controversies in prenatal diagnosis in multiples (CVS or amino)
S. lipitz, Israel
12:30-12:55 Selective fetocide in MC twins: Radiofrequency or bipolar cauterization?
T.Y. Leung, Hong Kong
12:55-13:15 Elective preterm delivery of MC twins
I. Blickstein, Israel
13:15-13:40 Elective fetal reduction: Early or late after nuchal screening?
S. lipitz, Israel

13:40-14:30 Lunch break

14:30-16:00
ULTRASOUND SCREENING FOR ANOMALIES
Chairpersons G. Yeo, Singapore
R. Achiron, Israel
Discussants:
Y. Gilboa, Israel
C. Anandakumar, Singapore
S. lipitz, Israel
R.K. Pooh, Japan
Questions to the panel:
  1. Early (14-16 weeks) or late (18-22 weeks) screening?
  2. What can be gained by combining transvaginal screening (TVS) with transabdominal screening (TAS) in late (24 weeks) sonographic screening?
  3. Screening for chromosomal abnormalities: Is there a role for second-trimester chemistry (i.e. sequential testing)?
  4. First-trimester evaluation of fetal anatomy: Can this replace second-trimester ultrasound?
  5. Elective fetal reduction: Early or late first trimester?
  6. Determination of fetal head station and position during labor
  7. A new technique that combines US and position-tracking system
  8. Route of delivery for the IUGR fetus

16:00-16:30 Coffee break

16:30-18:00
PRENATAL DIAGNOSIS
Capsule
The indication for prenatal diagnosis of anomalies is evolving quickly Neonatal Screening for Congenital disease that are treatable only if diagnosed during the first days of life expand the role of the Perinatologist and require constant updating
Chairperson C. Anandakumar, India
Y. Gilboa, Israel
16:30-16:50 First tier diagnostic testing for women with high risk pregnancy: Prenatal BoBs vs. rapid aneuploidy testing
R. Choy, Hong Kong
16:50-17:15 Non-invasive prenatal diagnosis of aneuploidies: Is it ready for routine use?
T.Y. Leung, Hong Kong
17:15-17:35 Are we doing the right thing in chasing for Downs syndrome
C. Anandakumar, India
17:35-18:00 CMV infections: The value of US and MRI in the assessment of pregnancies with primary CMV infection, is fetal late infection less vulnerable
S. lipitz, Israel

Saturday, July 21, 2012


08:30-10:00
SPECIAL ISSUES IN OBSTETRICS IN ASIA PACIFIC
Capsule
Converging on special situations in perinatology in Asia
Chairpersons G.C. Di Renzo, Italy
P.K. Shah, India
08:30-08:50 Management of suspected macrosomia for Asians: Same as Caucasian?
T.Y. Leung, Hong Kong
08:50-09:15 Diagnosis of IUGR in East Asia: Do the Western monograms apply?
A.W.C. Tan, Singapore
09:15-09:40 Treating anemia: National program in India
H. Divakar, India
09:40-10:00 How to reduce Maternal Mortality in India : A holistic approach."
P. K. Shah, India
Objectives Upon completion of this session, the audience will have learned about:
  • The nomograms of IUGR and Macrosomia in Asia
  • Reducing maternal morbidity and mortality

10:00-10:20 Coffee break

10:20-11:50
PREDICTION OF HYPERTENSIVE DISORDERS IN PREGNANCY
Capsule
Hypertensive disorders associated with underlying placental and maternal changes, that are also associated with endothelial dysfunction and vasospasm, can lead to placental insufficiency and serious consequences to the mother and infant. Various markers and tools for predicting the disorders were devised recently.  However, since the exact pathophysiological mechanism leading to this condition is still poorly understood, it is difficult to devise a prevention plan.  Hence, the question is, what is the benefit of prediction? Could close surveillance of the patient at risk prevent the pathology, or save maternal and fetal life? Should we keep investing in prediction in the absence of an ultimate preventive treatment?
Chairpersons I. Blickstein, Israel
T.Y. Leung, Hong Kong
10:20-11:20
Debate: Should we strive to predict pre-eclampsia? 

Proposition: Prediction is possible with newer methods, and this is the first step towards prevention.  Is it ready now?
L.W. Law, Hong Kong
Opposition: Investing in the prediction of pre-eclampsia is futile since there is no effective treatment
T. Wataganara, Thailand
Discussion
11:20-11:50 Are the current criteria valid for defining a casual relationship for cerebral palsy?
I. Blickstein, Israel
Objectives Upon completeion of this session, the audience will have learned about:
  • New research and tools to predict pre-eclampsia
  • The place of endothelial dysfunction measurements
  • Is prevention possible?

11:50-12:10 Poster viewing

12:10-13:40
PROGESTOGENS: FROM LUTEAL SUPPORT TO MISCARRIAGE PREVENTION
Supported by an unrestricted grant from Abbott
Capsule
The growing place of progestogens support during early pregnancy deserves critical evaluation. Many recent publications indicate the safety of various preparations in the management of threatened and recurrent miscarriage
Chairpersons A. Patki, India
P. van de Weijer, New Zeeland
12:10-12:40 The growing place of progestogens in prevention of miscarriage and early pregnancy complications
G.C. Di Renzo, Italy
12:40-13:10 Improving blood flow with progestogens as a method to prevent miscarriage
S. Daya, Canada
13:10-13:40 Dydrogesterone Review of the Evidence
H. Carp, Israel
Objectives Appreciating the increasing role of progestogens support to prevent miscarriage

13:40-14:30 Lunch break


14:30-16:00
CHALLENGES OF PERINTALA VIABILITY
Capsule
Despite great advances in perinatal medicine, the challanges of the gestational period from 22 to 26 weeks are still poignant for the perinatalogists
Chairpersons P. K. Shah, India
W.C. Tan, Singapore
14:30-14:50 Outcome of the periviable infant: Have we reached the limit?
M. Carrapato, Portugal
14:50-15:15 Postpartum hemorrhage: What can be done before hysterectomy?
I. Blickstein, Israel
15:15-15:35 Economic considerations in the management of the perviable infant
M. Carrapato, Portugal
15:35-16:00 Thrombophilia and autoimmune disease in implantation failure
B. Wiweko, Indonesia
Objectives Upon completion of this session, the audience will have learned:
  • To understand the burden of very premature delivery on medical, economical, societal and parental issues
  • To understand the risk of vaginal vs. Cesarean delivery for periviable infants

16:00-16:30 Coffee break

16:30-18:00
HOT CONTROVERSIES IN PERINATOLOGY
Chairpersons W.J. Ledger, USA
H. Divakar, India
16:30-17:00 Should we prefer emergency cerclage for conservative treatment of bulging membranes? Conservative treatment will achieve similar results without the risks involved
I. Blickstein, Israel

Discussion
  1. Shirodkar or MacDonald's cerclage
  2. Transvaginal cervical length screening should be routine practice?
17:00-17:30 Bacterial Vaginosis; Myths and reality
W.J. Ledger, USA
17:30-18:00 Deliveries of twins: Quo-Vadis?
I. Blickstein, Israel
Objectives Upon completion of this session, the audience will have learned:
  • The pitfalls of diagnosis, bulging of membranes and short cervix
  • Treatment of PTL
  • Selecting who to treat
  • Technique, indication, and contraindiction of late cerclage
  • Risks of Bacterial Vaginosis
    Future trends in Twins delivery

Sunday, July 22, 2012


08:30-10:00
FREE COMMUNICATION – FETOMATERNAL
Chairperson H. Divakar, India
08:30-08:36 Prospective risk of late stillbirth in singleton pregnancies: A regional cohort study
S. Kumarasiri, Sri Lanka
08:36-08:42 Caesarean myomectomy: A dangerous procedure?
O. Makinde, Nigeria
08:42-08:48 Is it necessary to do fetal post- mortem after intrauterine death?
A. Krishna, United Kingdom
08:48-08:54 Extirpative versus conservative management of placenta accreta: A provincial hospital experience
R. Arigue, Philippines
08:54-09:00 Laparoscopic management of intraligamentous pregnancy: Case report and literature review
S-Y. C. Cheung, Hong Kong
09:00-09:06 Nullipara with unengaged head at term-case for primary caesarean section?
R. Iyengar, India
09:06-09:12 Amnioinfusion with use to jugular venous pressure set (JVP set) to treat severe oligohydramnios in early premature rupture of membranes
H. Noerjasin, Indonesia
09:12-09:18 Maternal and perinatal outcome in HELLP syndrome
C. Kunjukunju, India
09:18-09:24 Substance abuse in pregnancy: Role of universal urine drug screening and addiction therapy in West Virginia
B. Cahoun, USA
09:24-09:30 Rising use of prenatal diagnosis and screening procedures leading to increased caesarean section: A part of defensive medicine in obstetrics
U. Bhatara, India
09:30-09:36 Are we managing in-utero fetal death appropriately?
A. Krishna, United Kingdom
09:36-09:42 NST: Is it a reliable predictor of fetal health?
R. Iyengar, India
09:42-09:48 MTP pills: Boon or bane?
U. Bhatara, India